Geographer produces new interactive map to show worldwide spread of coronavirus

Geographer produces new interactive map to show worldwide spread of coronavirus

Experts advise against using steroids for treatment of coronavirus Zhao specializes in the social implications of maps and using innovative methods in mapping. The outbreak of the coronavirus, which is believed to have originated in Wuhan, China in December, has been declared a public health emergency by the WHO. Tens of thousands have been infected, and hundreds have died. Zhao recently produced an online atlas to illustrate the global refugee experience. The coronavirus, he said, is another societal issue that people can gain perspective on by seeing it on a map. While the Chinese government has been criticized for its response to the crisis, and concerns have arisen about its transparency, Zhao said China's National Health Commission data is the most accurate available for the country. But the outbreak is not just affecting China or the city of Wuhan, he added. It is a global issue, and that's the perspective users can gain from the map. The numbers on display are important, too, he said, because there are more recoveries than deaths. "That can give people encouragement," he said. As more detailed data become available, Zhao plans to add county-level totals from China, and state and provincial totals from the United States and Canada, respectively. Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More